Bio-IT World News
YouTube Facebook LinkedIn TwitterInstagram rss
a-divisiion-of-chi
  • Subscribe
  • News
    • Latest News
    • View Press Releases
    • Post a Press Release
    • Reprint Articles
  • Podcast
  • Advertise
    • Media Kit
    • Digital Advertising
    • Lead Generation
    • Editorial Calendar
    • Webinars
    • Whitepapers
    • Podcasts
    • View Press Releases
    • Post a Press Release
  • Free Downloads
    • Whitepapers
    • Podcasts
    • Webinars
    • Inside eBooks
  • Events
    • Webinars
    • Industry Events
    • IT Conferences
    • Bio-IT World Expo
    • Bio-IT World Expo Europe
  • About Us
    • Editorial Profile
    • Editorial Calender
    • Contact Us
    • Submit a story
    • Innovative Practices Awards
    • Linking Policy
  • Bio-IT World Expo
    • Bio-IT World Boston
    • Bio-IT World Europe
 
 
 
 
  • Hovione expands nasal drug delivery capabilities with the development of nasal powder delivery device technology in collaboration with IDC

    Nov 30, 2023, 09:12 AM by
    Full story
  • CD Genomics Takes Genomic Research to New Heights with Ribo-seq Technology

    Nov 30, 2023, 09:12 AM by
    Full story
  • CD Genomics Launches Full-Length 16S/18S/ITS Amplicon Sequencing Service

    Nov 30, 2023, 09:12 AM by
    Full story
  • Follow the Money: AI-Designed De Novo Therapeutics, Spatial Technology, DNA Platform for Rheumatoid Arthritis, More

    Nov 30, 2023, 01:00 AM by User Not Found
    Bio-IT World | Absci and Almirall announced a drug discovery partnership aimed to develop and commercialize AI-designed therapeutics to fight chronic and debilitating dermatological diseases; Stellaromics is developing next-generation spatial technology that promises to accelerate the development of fundamentally novel drug treatments, including for autoimmune diseases, cancer, and more; Aqtual intends to expand its platform that evaluates protein regulation, epigenetics, and transcriptomics; more.
    Full story
  • InsightRX Brings Groundbreaking Advancements in Model-Informed Precision Dosing to the ASHP Midyear Conference

    Nov 29, 2023, 08:32 AM by
    InsightRX Brings Groundbreaking Advancements in Model-Informed Precision Dosing to the ASHP Midyear Conference
    Full story
  • Improving the Patient Experience With AI-Powered Medication History That Helps Streamline Admissions at Southlake Regional Health Centre

    Nov 29, 2023, 08:32 AM by
    DrFirst Healthcare Innovations has partnered with Southlake Regional Health Centre
    Full story
  • Exothera’s CTO Patrick Thiaville nominated as a member of Alliance for mRNA Medicines Board

    Nov 29, 2023, 08:32 AM by
    Exothera has announced its Nucleic Acids Chief Technology Officer, Patrick Thiaville has been nominated as a member of the Alliance for mRNA Medicines (AMM) board.
    Full story
  • "Prescribing the Future: 503A U.S. Compounding Pharmacies Market Soars to $7.18 Billion by 2032, Fueled by Surging Demand for Personalized Healthcare"

    Nov 29, 2023, 08:32 AM by
    The 503A U.S. compounding pharmacies market is not just witnessing growth; it's shaping the future of personalized healthcare. As demand intensifies, regulatory challenges persist, and innovative solutions emerge, these pharmacies stand at the intersection of patient-centric care and technological advancement, promising a transformative journey ahead.
    Full story
  • Greenphire, Florence Healthcare Team Up; Illumina Partnerships; Oxford Nanopore Develops New Data Technology

    Nov 29, 2023, 01:00 AM by User Not Found
    Bio-IT World | Greenphire and Florence Healthcare announce a technology partnership; Illumina and Veracyte join together in a multi-year agreement; Oxford Nanopore Technologies collaborates with Fabric Genomics and Saphetor to develop data technology for research; more.
    Full story
  • Northern Virginia Technology Council Recognizes DrFirst as a Top Tech Leader for Fourth Consecutive Year

    Nov 28, 2023, 09:02 AM by
    Northern Virginia Technology Council Recognizes DrFirst as a Top Tech Leader for Fourth Consecutive Year
    Full story
  • Profacgen Updates Its Fermentation Process Development Solutions

    Nov 28, 2023, 09:02 AM by
    Full story
  • Creative BioMart Unveils Comprehensive Lectin Portfolio for Diverse Research Applications

    Nov 28, 2023, 09:02 AM by
    Full story
  • Matexcel Enlarged Its Offerings for Bioglass Products

    Nov 28, 2023, 09:02 AM by
    Full story
  • Lifeasible Enhanced Its Plant Metabolite Profiling Services

    Nov 28, 2023, 09:01 AM by
    Full story
  • Creative Enzymes Unveils Cutting-edge Homocysteine Methyltransferase, Recombinant for Enhanced Bioprocessing

    Nov 28, 2023, 09:01 AM by
    Full story
  • Creative Enzymes Introduces S-Adenosyl-L-Homocysteine Hydrolase, Recombinant

    Nov 28, 2023, 09:01 AM by
    Full story
  • IntegrateRNA Unveils Revolutionary Self-Amplifying RNA In Vitro Synthesis Service

    Nov 28, 2023, 09:01 AM by
    Full story
  • Creative Proteomics Unleashes the Exosome Untargeted Metabolomics Service

    Nov 28, 2023, 09:01 AM by
    Full story
  • Creative Biogene Provides One-stop PEM-Seq Service to Assess Off-target Effect of CRISPR/Cas9

    Nov 28, 2023, 09:01 AM by
    Full story
  • Creative Proteomics Enhances Proteomics Research with Advanced Post-Translational Modification Analysis Services

    Nov 28, 2023, 09:01 AM by
    Full story
  • «
  • 61
  • 62
  • 63
  • 64
  • 65 (current)
  • 66
  • 67
  • 68
  • 69
  • 70
  • »
 
CHI | Cambridge HealthTech Institute

250 First Avenue, Suite 300
Needham, MA 02494

P: 781.972.5400
F: 781.972.5425
E: chi@healthtech.com

Life Science Portals

Biological Therapeutic Products

Biomarkers & Diagnostics

Biopharma Strategy

Bioprocess & Manufacturing

Chemistry

Clinical Trials &
Translational Medicine

Drug & Device Safety

Drug Discovery & Development

Drug Targets

Healthcare

IT, AI, ML & Informatics

Technology & Tools For
Life Science

Therapeutic Indications

Venture, Innovation & Partnering

CHI Divisions

Conferences

Reports & Market Research

News & Advertising

Professional Services

Corporate Information

Cambridge Innovation
Institute

Executive Team

Testimonials

Mailing List

Careers


Request Information

Privacy Policy